Full View

Late-term clinical outcomes with zotarolimus-and sirolimus-eluting stents: 5-Year follow-up of the ENDEAVOR III (A randomized controlled trial of the Medtronic …

DE Kandzari, L Mauri, JJ Popma, MA Turco… - JACC: Cardiovascular …, 2011 - jacc.org
Objectives: This study sought to compare late safety and efficacy outcomes following
percutaneous coronary revascularization with zotarolimus-eluting stents (ZES) and sirolimus …
被引用次数：144 相关文章

Late-term clinical outcomes with zotarolimus-and sirolimus-eluting stents: 5-Year follow-up of the ENDEAVOR III (a randomized controlled trial of the Medtronic …

DE Kandzari, L Mauri, JJ Popma… - JACC …, 2011 - pure.johnshopkins.edu
Objectives: This study sought to compare late safety and efficacy outcomes following
percutaneous coronary revascularization with zotarolimus-eluting stents (ZES) and sirolimus …

[引用][C] Late-Term Clinical Outcomes With Zotarolimus-and Sirolimus-Eluting Stents

DE Kandzari, L Mauri, JJ Popma, MA Turco… - JACC: Cardiovascular …, 2011 - cir.nii.ac.jp
Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …

Late-Term Clinical Outcomes With Zotarolimus-and Sirolimus-Eluting Stents

DE Kandzari, L Mauri, JJ Popma, MA Turco… - JACC: Cardiovascular …, 2011 - infona.pl
This study sought to compare late safety and efficacy outcomes following percutaneous
coronary revascularization with zotarolimus-eluting stents (ZES) and sirolimus-eluting stents …

Late-term clinical outcomes with zotarolimus-and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic …

DE Kandzari, L Mauri, JJ Popma, MA Turco, PA Gurbel… - 2011 - pubmed.ncbi.nlm.nih.gov
Objectives This study sought to compare late safety and efficacy outcomes following
percutaneous coronary revascularization with zotarolimus-eluting stents (ZES) and sirolimus …

Late-term clinical outcomes with zotarolimus-and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic …

DE Kandzari, L Mauri, JJ Popma, MA Turco… - JACC …, 2011 - europepmc.org
Objectives This study sought to compare late safety and efficacy outcomes following
percutaneous coronary revascularization with zotarolimus-eluting stents (ZES) and sirolimus …
[HTML] sciencedirect.com

[HTML][HTML] Late-Term Clinical Outcomes With Zotarolimus-and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the …

DE Kandzari, L Mauri, JJ Popma, MA Turco… - JACC: Cardiovascular …, 2011 - Elsevier
Objectives This study sought to compare late safety and efficacy outcomes following
percutaneous coronary revascularization with zotarolimus-eluting stents (ZES) and sirolimus …
[PDF] core.ac.uk

[PDF][PDF] Late-Term Clinical Outcomes With Zotarolimus-and Sirolimus-Eluting Stents

DE Kandzari, L Mauri, JJ Popma, MA Turco… - JACC …, 2011 - core.ac.uk
Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents Page 1 Late-Term
Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents 5-Year Follow-Up of the …